Roche Enterprise Value Over E B I T D A from 2010 to 2026
| ROG Stock | CHF 358.70 1.90 0.53% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 15.68066805 | Current Value 15.61 | Quarterly Volatility 3.19721452 |
Check Roche Holding financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Roche Holding's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 B, Interest Expense of 964.3 M or Selling General Administrative of 15.9 B, as well as many indicators such as Price To Sales Ratio of 4.33, Dividend Yield of 0.0214 or PTB Ratio of 6.3. Roche financial statements analysis is a perfect complement when working with Roche Holding Valuation or Volatility modules.
Roche | Enterprise Value Over E B I T D A |
The evolution of Enterprise Value Over E B I T D A for Roche Holding AG provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Roche Holding compares to historical norms and industry peers.
Latest Roche Holding's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Roche Holding AG over the last few years. It is Roche Holding's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Roche Holding's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Roche Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 13.69 | |
| Geometric Mean | 13.42 | |
| Coefficient Of Variation | 23.35 | |
| Mean Deviation | 2.01 | |
| Median | 12.91 | |
| Standard Deviation | 3.20 | |
| Sample Variance | 10.22 | |
| Range | 14.4885 | |
| R-Value | (0.06) | |
| Mean Square Error | 10.86 | |
| R-Squared | 0 | |
| Significance | 0.81 | |
| Slope | (0.04) | |
| Total Sum of Squares | 163.55 |
Roche Enterprise Value Over E B I T D A History
About Roche Holding Financial Statements
Roche Holding investors use historical fundamental indicators, such as Roche Holding's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Roche Holding. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 15.68 | 15.61 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Roche Stock Analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.